← FDA Drug Approvals (Drugs@FDA)
CYCLOSPORINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JIANGSU ANBISON · Approved 2026-06-01
Drug application
- FDA Application #
ANDA219288- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CYCLOSPORINE
- Generic name
- Cyclosporine
- Active ingredients
- CYCLOSPORINE
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- JIANGSU ANBISON
- First approval
- 2026-06-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown